Iridium-192 interstitial brachytherapy as adjunctive treatment for canine cutaneous mast cell tumors

Journal of the American Animal Hospital Association

Volumn 40, Issue 4, 2004, Pages 309-315

  Northrup, Nicole C ^a   Roberts, Royce E ^a   Harrell, Todd W ^b   Allen, Karen L ^a   Howerth, Elizabeth W ^a   Gieger, Tracy L ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IRIDIUM 192;

ARTICLE; BRACHYTHERAPY; DISEASE SEVERITY; DOG DISEASE; FEMALE; FOLLOW UP; MALE; MASTOCYTOMA; NONHUMAN; RADIATION DOSE; RADIATION FIELD; RADIATION SICKNESS; SKIN SURGERY; SKIN TUMOR; SURVIVAL; TUMOR RECURRENCE;

CANIS FAMILIARIS;

EID: 13844284001     PISSN: 15473317     EISSN: 15473317     Source Type: Journal    
DOI: 10.5326/0400309     Document Type: Article

References (29)

1. Turrel JM, Kitchell BE, Miller LM, et al. Prognostic factors for radiation treatment of mast cell tumors in 85 dogs. J Am Vet Med Assoc 1988;193:936-940.
2. Al-Sarraf R, Mauldin GN, Patnaik AK, et al. A prospective study of radiation therapy for the treatment of grade 2 mast cell tumors in 32 dogs. J Vet Intern Med 1996;10:376-378.
3. Frimberger AE, Moore AS, LaRue SM, et al. Radiotherapy of incompletely resected, moderately differentiated mast cell tumors in the dog: 37 cases (1989-1993). J Am Anim Hosp Assoc 1997;33:320-324.
4. LaDue T, Price GS, Dodge R, et al. Radiation therapy for incompletely resected canine mast cell tumors. Vet Radiol Ultrasound 1998;39:57-62.
5. Turrel JM, Koblik PD. Techniques of afterloading iridium-192 interstitial brachytherapy in veterinary medicine. Vet Radiol 1983;24:278-283.
6. Walker MA. Interstitial implant brachytherapy in small animals. Vet Clin North Am Small Anim Pract 1997;27:59-71.
7. Nag S, Shasha D, Janjan N, et al. The American Brachytherapy Society recommendations for brachytherapy of soft tissue sarcomas. Int J Radiation Oncol Biol Phys 2001;49:1033-1034.
8. Patnaik AK, Ehler WJ, MacEwen SJ. Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Vet Pathol 1984;21:469-474.
9. Williamson JF. The physics of brachytherapy. In: Perez CA, Brady LW, eds. Principles and Practice of Radiation Oncology. 3rd ed. Philadelphia: Lippincott-Raven Publishers, 1997:441-442.
10. Johns HE, Cunningham JR. The Physics of Radiology. 4th ed. Springfield, IL: Charles C. Thomas Publisher, 1983:466-474.
11. LaDue T, Klein MK. Toxicity criteria of the Veterinary Radiation Therapy Oncology Group. Vet Radiol Ultrasound 2001;42:475-476.
12. White R, Walker M, Legendre AM, et al. Development of brachytherapy technique for nasal tumors in dogs. Am J Vet Res 1990;51:1250-1256.
13. 192Iridium brachytherapy, using an intracavitary afterload device, for treatment of intranasal neoplasms in dogs. Am J Vet Res 1992;53:617-622.
14. Close LG, Morrish TN, Nguyen P. Intraoperative versus interstitial radiotherapy: a comparison of morbidity in the head and neck. Laryngoscope 1993;103:231-246.
15. Hilaris BS, Bodner WR, Mastoras CA. Role of brachytherapy in adult soft tissue sarcomas. Semin Surg Oncol 1997;13:196-203.
16. Merchant TE, Parsh N, del Valle PL, et al. Brachytherapy for pediatric soft-tissue sarcoma. Int J Radiation Oncol Biol Phys 2000;46:427-432.
17. Perez CA, Grigsby PW, Williamson JF. Clinical applications of brachytherapy I: low dose rate. In: Perez CA, Brady LW, eds. Principles and Practice of Radiation Oncology. 3rd ed. Philadelphia: Lippincott-Raven Publishers, 1997:523-525.
18. Walker M, Adams W, Hoskinson J, et al. Iridium-192 brachytherapy for equine sarcoid, one and two year remission rates. Vet Radiol 1990;32:206.
19. Théon A, Pascoe J. Iridium-192 interstitial brachytherapy for equine periocular tumors: treatment results and prognostic factors in 115 horses. Equine Vet J 1994;27:117.
20. Michels GM, Knapp DW, DeNicola DB, et al. Prognosis following surgical excision of canine cutaneous mast cell tumors with histopathologically tumor-free versus non-tumor-free margins. J Am Anim Hosp Assoc 2002;38:458-466.
21. Weisse C, Shofer FS, Sorenmo K. Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision. J Am Anim Hosp Assoc 2002;38:71-73.
22. Séguin B, Leibman NF, Bregazzi VS, et al. Clinical outcome of dogs with grade-II mast cell tumors treated with surgery alone: 55 cases (1996-1999). J Am Vet Med Assoc 2001;218:1120-1123.
23. McCaw DL, Miller MA, Ogilvie GK, et al. Response of canine mast cell tumors to treatment with oral prednisone. J Vet Intern Med 1994;8:406-408.
24. Gerritsen RJ, Teske E, Kraus JS, et al. Multi-agent chemotherapy for mast cell tumours in the dog. Vet Quart 1998:28-31.
25. Thamm DH, Mauldin EA, Vail DM. Prednisone and vinblastine chemotherapy for canine mast cell tumor - 41 cases (1992-1997). J Vet Intern Med 1999;13:491-497.
26. Rassnick KM, Moore AS, Williams LE, et al. Treatment of canine mast cell tumors with CCNU (Lomustine). J Vet Intern Med 1999;13:601-605.
27. Pisters PW, Harrison LB, Leung DH, et al. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 1996;14:859-868.
28. Thrall DE, Goldschmidt MH, Biery DN. Malignant tumor formation at the site of previously irradiated acanthomatous epulides in four dogs. J Am Vet Med Assoc 1981;178:127-132.
29. Gillette SM, Gillette EL, Powers BE, et al. Radiation-induced osteosarcomas in dogs after external beam or intraoperative radiation therapy. Cancer Res 1990;50:54-57.